New advisory council studies Medicaid financing models to expand equitable access to sickle cell and high-cost drug treatments
WASHINGTON, D.C. – The newly formed Advisory Council on Financing and Access to Sickle Cell Disease Treatment and Other High-Cost Drugs and Treatmenthas begun its work to study options and make recommendations for developing payment models and financing structures for novel Sickle Cell Disease treatments, as well as other high-cost drugs and therapies that are […]